Imagine a world where doctors could give their patients a list of every clinical trial they are eligible to join.

From repairing deadly brain bleeds to tackling tumors with precise chemotherapy, micro/nano-robots (MNRs) are a promising, up ...

In a discussion with the Cobb Institute, Dr. Priscilla Pemu and Tesheia Harris shared insights on how to make clinical trials more inclusive.

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

USC professor Berislav Zlokovic is on leave after whistleblowers cast doubt on his published work and derailed trials for an ...

Endowed Professor and Director of the MSM Cardiovascular Research Institute will be honored during upcoming AHA Scientific ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

A promising daily tablet is effective at increasing height and improving proportional limb growth in children with ...

Professor Marianna Fontana ... Professors Fontana and Gillmore are currently running a global Phase III clinical trial ...

Joan Carpenter, PhD, CRNP, ACHPN, FPCN, receives the 2024 Excellence in Research Award from the Gerontological Advanced Practice Nurses Association.

Jaime Merchan, MD, discusses the background and findings from the LITESPARK-013 trial of belzutifan for the treatment of patients with advanced clear cell renal cell carcinoma.